about
B-Raf and the inhibitors: from bench to bedsideConsensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseasePreappointment testing for BRAF/KIT mutation in advanced melanoma: a model in molecular data delivery for individualized medicineImmunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib.BRAF gene: From human cancers to developmental syndromes.Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.Laryngeal Langerhans Cell Histiocytosis Presenting with Neck Mass in an Adult Woman.High-resolution melting analysis for accurate detection of BRAF mutations: a systematic review and meta-analysis.KRAS mutation testing in clinical practice.Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma.Mismatch repair deficiency testing in clinical practice.Molecular pathology as the driving force for personalized oncology.Discrepant results for BRAF V600E mutation among different specimens in a case of hairy cell leukemia.The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation.BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.The diagnostic role and clinical relevance of determination of BRAF status in brain tumors.
P2860
Q21198860-C90D25B5-E4A0-4A8E-BA0D-3037FE21C47FQ28240576-075C244E-58BB-4E08-B4C4-646155EDC82EQ30847040-9C3363E7-6047-461A-BFC0-3913A14418ACQ34520869-96DE16C1-F84B-482D-BE79-BE6EC6C5A620Q34551705-E5163CFC-6E99-4537-A167-8AB72F66C24AQ35802430-712053EB-3687-4608-9BDB-186833F57F65Q36392912-ADC12817-9B6E-474B-8871-E981FE934F2BQ36809815-4700305E-E572-4899-961C-4DA11BC90E04Q37601544-6D78397C-9313-4259-957D-670B824F93A3Q38285393-24DC8B94-CF84-442A-85B8-21C3741B3B2BQ38682192-0753979B-AC23-461C-9BDC-208B9FA5A610Q38741029-7AA93278-CEE3-4C41-9046-AA91C7AFDC76Q39501574-0CD1446C-02AB-46C1-A3E6-ED20B3F0629DQ43109505-A86CDC4D-187E-4A23-91A9-3F47FFD74CD4Q43740818-D6C1535D-F911-4198-8D32-CB33909CC3B6Q44428665-B317BEB5-C9B4-41B6-B846-D509BCA1B432Q53265606-CF6A4A70-67FD-400A-A56C-C3EB2A69DE51Q54266014-2F98AFC9-D575-41AD-9F93-7D51F08155B2Q55461604-647EB852-E50E-48E2-8C6B-6D9DCC207220
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
BRAF mutation testing in clinical practice.
@en
BRAF mutation testing in clinical practice.
@nl
type
label
BRAF mutation testing in clinical practice.
@en
BRAF mutation testing in clinical practice.
@nl
prefLabel
BRAF mutation testing in clinical practice.
@en
BRAF mutation testing in clinical practice.
@nl
P2860
P356
P1476
BRAF mutation testing in clinical practice.
@en
P2093
P2860
P304
P356
10.1586/ERM.12.1
P577
2012-03-01T00:00:00Z